Zora Nešković‐Konstantinović

Author

Also Known As

Z Neskovic-Konstantinovic, Z Nesković-Konstantinović, Z Nešković-Konstantinović, Z. Neskovic-Konstantinovic, Z. Nešković-Konstantinović, Z.B. Neskovic-Konstantinovic, Zora B Nešković-Konstantinović, Zora B. Nešković-Konstantinović, Zora Neskovic-Konstantinovic, Zora Nesković-Konstantinović

111

Publications

886

Citations

H-Index

Concepts

All Affiliations

Oncology Institute of Vojvodina Vinča Institute of Nuclear Sciences University of Belgrade

About

Zora Nešković‐Konstantinović is an author at Oncology Institute of Vojvodina specializing in breast cancer, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	340
2	Cell Biology	3	3	64
3	Endocrinology	2	2	30
4	Immunology	2	2	32
5	Nursing	1	1	18

Zora Nešković‐Konstantinović

Publications

771

Citations

H-Index

Page 1

	Year	Citations
Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer Antonio C. Wolff, Ann Lazar, Igor Bondarenko, Journal of Clinical Oncology	2012	272
Elevated plasma levels of transforming growth factor-β1 (TGF-β1) in patients with advanced breast cancer: association with disease progression Vesna Ivanović, Nataša Todorović‐Raković, Miroslav Demajo, European Journal of Cancer Advanced Breast CancerBreast OncologyDisease ProgressionPlasma LevelsMedicine	2003	138
Attitudes of young patients with breast cancer toward fertility loss related to adjuvant systemic therapies. EORTC study 10002 BIG 3‐98 Elżbieta Senkus, Henry Gómez, Luc Dirix, Psycho-Oncology	2013	77
Prognostic value of HER2 gene amplification detected by chromogenic in situ hybridization (CISH) in metastatic breast cancer Nataša Todorović‐Raković, Danica Jovanović, Zora Nešković‐Konstantinović, Experimental and Molecular Pathology Metastatic Breast CancerBreast OncologyMedicinePrognostic ValuePathology	2007	27
Daily oral etoposide in metastatic breast cancer Zora Nešković‐Konstantinović, Snežana Bošnjak, Siniša Radulović, Anti-Cancer Drugs	1996	27
Plasma TGF-β1-related survival of postmenopausal metastatic breast cancer patients Dragica Nikolić‐Vukosavljević, Nataša Todorović‐Raković, Miroslav Demajo, Clinical & Experimental Metastasis Breast OncologyPlasma Tgf-β1-related SurvivalMedicinePathologyBreast Cancer	2005	24
Expression of estrogen receptor β wt isoform (ERβ1) and ERβΔ5 splice variant mRNAs in sporadic breast cancer Vesna Mandušić, Dragica Nikolić‐Vukosavljević, Nikola Tanić, Journal of Cancer Research and Clinical Oncology Tumor BiologyTranscriptional RegulationSystems BiologyBreast OncologyHormonal Receptor	2007	20
Comparison between immunohistochemistry and chromogenic <i>in situ</i> hybridization in assessing HER‐2 status in breast cancer Nataša Todorović‐Raković, Danica Jovanović, Zora Nešković‐Konstantinović, Pathology International	2005	20
Natural History of Estrogen Receptor-Negative, Progesterone Receptor-Positive Breast Cancer Dragica Nikolić‐Vukosavljević, Ksenija Kanjer, Zora Nešković‐Konstantinović, The International Journal of Biological Markers Breast OncologyMedicineHormonal ReceptorNatural HistoryPgr-positive Breast Carcinomas	2002	19
Different associations of estrogen receptor β isoforms, ERβ1 and ERβ2, expression levels with tumor size and survival in early- and late-onset breast cancer Vesna Mandušić, Bogomir Dimitrijević, Dragica Nikolić‐Vukosavljević, Cancer Letters Tumor BiologyExpression LevelsBreast OncologyLate-onset Breast CancerEndocrine-related Cancer	2012	19

Page 1